Overview
Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation is a rare genetic brain disorder caused by changes (mutations) in the GRIN2A gene. This gene provides instructions for making a protein that is part of a receptor called NMDA, which plays a critical role in how brain cells communicate with each other, especially during learning and memory formation. When this gene is not working properly, it can lead to seizures that begin early in life, often in infancy or early childhood, along with significant delays in thinking, learning, and development. Children with this condition typically experience frequent and sometimes severe seizures that can be difficult to control with standard medications. The seizures themselves, combined with the underlying brain dysfunction, contribute to what doctors call "epileptic encephalopathy" — a situation where the seizure activity itself worsens brain function over time. Intellectual disability can range from mild to severe, and many children also have speech and language difficulties, which is a hallmark feature of GRIN2A-related disorders. There is currently no cure for this condition. Treatment focuses on controlling seizures with anti-seizure medications, though finding the right combination can be challenging. Speech therapy, occupational therapy, physical therapy, and special education services are important parts of the overall care plan. Research into targeted therapies that address the specific NMDA receptor dysfunction is ongoing and offers hope for more effective treatments in the future.
Key symptoms:
Seizures that start early in lifeIntellectual disabilitySpeech and language delaysDifficulty learning new skillsMovement problems or clumsinessBehavioral difficultiesAttention problemsMuscle tone abnormalities (too stiff or too floppy)Sleep disturbancesDifficulty with fine motor skills like writing or buttoning clothesSocial interaction challengesRegression or loss of previously learned skills during seizure episodesFeeding difficulties in infancy
Clinical phenotype terms (29)— hover any for plain English
Variable
Can be inherited in different ways depending on the underlying gene
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation.
Community
No community posts yet. Be the first to share your experience with Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation.
Start the conversation →Latest news about Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
No recent news articles for Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific GRIN2A mutation does my child have, and what does it mean for their outlook?,Which anti-seizure medications are most likely to help, and what side effects should I watch for?,Are there any targeted or experimental therapies being studied for GRIN2A-related epilepsy?,How often should my child have EEGs and developmental assessments?,What therapies (speech, occupational, physical) should we start, and how often?,What should I do if my child has a prolonged seizure — do we need a rescue medication at home?,Should other family members be tested for the GRIN2A mutation, and what is the chance of this happening again in a future pregnancy?
Common questions about Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
What is Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation?
Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation is a rare genetic brain disorder caused by changes (mutations) in the GRIN2A gene. This gene provides instructions for making a protein that is part of a receptor called NMDA, which plays a critical role in how brain cells communicate with each other, especially during learning and memory formation. When this gene is not working properly, it can lead to seizures that begin early in life, often in infancy or early childhood, along with significant delays in thinking, learning, and development. Children with
At what age does Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation typically begin?
Typical onset of Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation is infantile. Age of onset can vary across affected individuals.